Brasada Capital Management’s Sanofi SNY Stock Holding History

Brasada Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,000	Closed	-$550K	–	137
2022 Q2	$550K	Buy	+11,000	New	+$584K	0.12%	100

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brasada Capital Management's SNY Position: Q3 2022 in Review

Brasada Capital Management sold out of Sanofi (SNY) in Q3 2022, closing a stake of 11,000 shares — an estimated $550K sold.

Brasada Capital Management first reported a position in SNY in Q2 2022 and held it in 1 quarter. The position peaked at $550K in Q2 2022. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

Brasada Capital Management reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
Brasada Capital Management sold 11,000 Sanofi shares in Q3 2022, an estimated $550K.
Brasada Capital Management first reported a position in Sanofi in Q2 2022 and held it in 1 quarter.
Brasada Capital Management's Sanofi position peaked at $550K in Q2 2022.
587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Brasada Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.